Search results
You searched for:
Found 1,536 results
Sorting options:
Date: 01/01/2026 Location: Other
This practice review is an engaging, case-based eLearning module designed to support GPs in managing long-term antidepressant use. Centred around the story of Darlene—an older patient unsure about continuing her medication—this self-paced course provides practical, evidence-based guidance on when and how to safely deprescribe. GPs will refine their clinical judgement, learn to address common patient concerns about withdrawal and relapse, and develop personalised tapering plans aligned with best practice. The module enhances confidence in navigating deprescribing discussions with empathy, ensuring patients are supported at every step.
1 Educational activity hour
Culturally safe practice
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This activity provides you with the tools to conduct a review of your adult patients who have been diagnosed with gout. During this case based discussion, you will be able to review your current management practices against the latest recommendations, reflect on necessary practice changes to optimise treatment outcomes, and ensure patient-centred care in line with evidence-based guidelines.
1 Performance review hour
Professionalism
Date: 01/01/2026 Location: Other
Foundation Dermal Fillersis a foundation component of Anatomy For Injectors which focuses on basic facial anatomy and laying the right groundwork for practitioners new to filler injections.Beginners will be introduced to the three most basic areas in dermal filler injections, namely the lateral cheeks, anterior cheeks and lips.
2 Educational activity hours
Date: 01/01/2026 Location: Other
This self-led session has been designed specifically for GPs to run in their practice. It aims to get the GP facilitator and their peers comfortable with the more challenging aspects of Eczema cases. Managing eczema involves a multifaceted approach; thorough examination and history taking, tailoring treatments to the individual, and managing patient expectations.
1.5 Educational activity hours
1.5 Performance review hours
Professionalism
Date: 01/01/2026 Location: Other
Eczema care goes beyond prescribing moisturisers and topical corticosteroids (TCS). Patients often have concerns about treatment safety—fueled by social media and conflicting advice. With this AI-driven course, you’ll gain the tools and strategies to confidently address these fears and guide your patients through informed decision-making. Smart Conversations for Eczema: AI-Enhanced Motivational Interviewing, is designed to help health professionals navigate challenging patient conversations, using eczema management and the use of TCS as a key case study.
0.5 Educational activity hour
0.5 Performance review hour
Professionalism
Date: 01/01/2026 Location: Other
This mini-audit activity provides GP’s with the tools to conduct a chart review of their paediatric patients who have been diagnosed/receiving treatment for eczema. During the audit, they will be able to review their current management practices against the recommendations and reflect on what practice changes they can make to optimise treatment outcomes, and ensure patient-centred care in line with evidence-based guidelines is provided.
1 Educational activity hour
2.5 Outcome measurement hours
Date: 01/01/2026 Location: Other
Gout is a chronic condition characterised by sudden, severe pain, swelling, redness and tenderness in one or more joints, most commonly the first metatarsophalangeal joint.It is one of the most common inflammatory joint diseases globally and locally, and presents a significant burden for many people in Australia. Self-reported prevalence rates are between 4.5% and 6.8% and it is more common among males and certain ethnic groups.This mini-audit activity provides you with the tools to conduct a review of your adult patients who have been diagnosed with gout, andamp; you will be able to review your current management practices against best practice recommendations.
0.5 Educational activity hour
2.5 Outcome measurement hours
Culturally safe practice
Ethical practice
Addressing health inequities
Professionalism
Date: 01/01/2026 Location: Other
Intermediate Dermal Fillersis an intermediate component of Anatomy For Injectors which focuses on contouring and rejuvenation techniques of the lower face, namely chin and jawline reshaping, sub-zygomatic volumisation and treatment of the oral commissures (marionette lines).
Date: 01/01/2026 Location: Other
Approximately 1 in 4 Australians aged over 65 were prescribed antidepressants in 2022-2023, a rate substantially higher than the 1 in 7 reported across all age groups – despite older adults reporting lower rates of depression and anxiety.Additionally, the average duration of antidepressant therapy in Australia is about fouryears, which exceeds current guideline recommendations are of 6–12 months for a single episode of depression and at least 12 months for managing anxiety, after an acceptable response is achieved.These discrepancies raise concerns about the impacts of both unnecessary and prolonged medication use, especially in older adults who have increased sensitivity to the adverse effects and long-term harms of antidepressants.
1.5 Educational activity hours
2.5 Outcome measurement hours
Ethical practice
Professionalism
Culturally safe practice
Addressing health inequities
Date: 01/01/2026 Location: Other
Gout is a chronic condition characterised by sudden, severe pain, swelling, redness, and tenderness in one or more joints, most commonly affecting the first metatarsophalangeal joint.It is one of the most prevalent inflammatory joint diseases both globally and locally, posing a significant burden for many individuals in Australia. Self-reported prevalence rates range from 4.5% to 6.8%, with higher occurrences among males and specific ethnic groups.Despite its high prevalence, gout remains significantly undertreated, resulting in unnecessary pain, disability, and diminished quality of life. Fewer than 60% of patients are prescribed urate-lowering therapy (ULT), and among those prescribed ULT, less than 1 in 10 receive co-prescribed flare prophylaxis at the time of initiation. Additionally, among patients on therapy, fewer than 50% achieve target serum uric acid levels. Compounding this issue is the stigma surrounding gout, which discourages many individuals from seeking treatment or adhering to prescribed regimens.
0.5 Performance review hour
Professionalism
Ethical practice